Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Pathways reviewed by Burgess, Andrew (2168074)
Details on Person Burgess, Andrew
| Class:Id | Person:2168074 |
| _displayName | Burgess, Andrew |
| _timestamp | 2016-07-20 19:16:28 |
| affiliation | [Affiliation:2506918] Garvan Institute of Medical Research |
| created | [InstanceEdit:2168071] Orlic-Milacic, M, 2012-03-23 |
| crossReference | [DatabaseIdentifier:5626742] ORCID:0000-0003-4536-9226 |
| firstname | Andrew |
| initial | A |
| modified | [InstanceEdit:2168076] Orlic-Milacic, M, 2012-03-23 [InstanceEdit:2506919] Orlic-Milacic, M, 2012-10-04 [InstanceEdit:5626745] Matthews, Lisa, 2014-10-10 [InstanceEdit:8932050] D'Eustachio, Peter, 2016-07-20 |
| surname | Burgess |
| (author) | [InstanceEdit:2506914] Burgess, A, 2012-09-28 [LiteratureReference:2168075] The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A [LiteratureReference:2467588] Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance [LiteratureReference:2506900] Characterization of the mechanisms controlling Greatwall activity [LiteratureReference:9754579] Inhibition of S/G2 phase CDK4 reduces mitotic fidelity |
|
[Change default viewing format]
|